Elevated lipolysis in adipose tissue by doxorubicin via PPARα activation associated with hepatic steatosis and insulin resistance

MLA

V G Abilash, et al. “Elevated Lipolysis in Adipose Tissue by Doxorubicin via PPARα Activation Associated with Hepatic Steatosis and Insulin Resistance.” European Journal of Pharmacology, vol. 843, Jan. 2019, pp. 162–76. EBSCOhost, https://doi.org/10.1016/j.ejphar.2018.11.018.

APA

V G Abilash, Sujitha Parthiban, K B Sruthy, Kaviyarasi Renu, Shubhankar Suman, Sankarganesh Arunachalam, S Sugunapriyadharshini, Alex George, & P.B. Tirupathi Pichiah. (2019). Elevated lipolysis in adipose tissue by doxorubicin via PPARα activation associated with hepatic steatosis and insulin resistance. European Journal of Pharmacology, 843, 162–176. https://doi.org/10.1016/j.ejphar.2018.11.018

Chicago

V G Abilash, Sujitha Parthiban, K B Sruthy, Kaviyarasi Renu, Shubhankar Suman, Sankarganesh Arunachalam, S Sugunapriyadharshini, Alex George, and P.B. Tirupathi Pichiah. 2019. “Elevated Lipolysis in Adipose Tissue by Doxorubicin via PPARα Activation Associated with Hepatic Steatosis and Insulin Resistance.” European Journal of Pharmacology 843 (January): 162–76. doi:10.1016/j.ejphar.2018.11.018.